MarkWide Research

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 310-961-4489

24/7 Customer Support

All our reports can be tailored to meet our clients’ specific requirements, including segments, key players and major regions,etc.

Global Polio Vaccine market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2024-2032

Published Date: April, 2024
Base Year: 2023
Delivery Format: PDF+ Excel
Historical Year: 2017-2023
No of Pages: 263
Forecast Year: 2024-2032
Category

Corporate User License

$3,450.00

Market Overview: The global polio vaccine market is witnessing significant growth due to the ongoing efforts to eradicate polio and the widespread immunization campaigns conducted by governments and international organizations. Polio vaccines are crucial in preventing the transmission of the poliovirus and protecting individuals from polio infection. The market is driven by factors such as increasing awareness about the importance of vaccination, government initiatives to achieve polio eradication goals, and advancements in vaccine manufacturing technologies. However, challenges such as vaccine supply chain issues and vaccine hesitancy pose restraints to market growth.

Meaning: Polio vaccines are biopharmaceutical products designed to induce immunity against the poliovirus, which causes polio. They are administered through injection or oral drops and work by stimulating the body’s immune system to produce antibodies that can recognize and neutralize the poliovirus. Polio vaccines have played a crucial role in reducing the global burden of polio and preventing new cases of the disease. They are available in various forms, including inactivated polio vaccine (IPV) and oral polio vaccine (OPV), and are recommended as part of routine immunization schedules worldwide.

Executive Summary: The global polio vaccine market is experiencing steady growth as efforts to eradicate polio continue worldwide. Polio vaccines are critical in preventing the transmission of the poliovirus and protecting individuals from the debilitating effects of polio. The market is driven by increasing awareness about the importance of vaccination, government initiatives to achieve polio eradication goals, and advancements in vaccine manufacturing technologies. However, challenges such as vaccine supply chain issues and vaccine hesitancy pose barriers to market growth. The market is characterized by the presence of established vaccine manufacturers and collaborations between governments, international organizations, and vaccine manufacturers to ensure widespread vaccine distribution.

Global Polio Vaccine Market

Key Market Insights:

  • The global polio vaccine market is witnessing growth due to the ongoing efforts to eradicate polio and the implementation of immunization programs worldwide.
  • Increasing awareness about the benefits of polio vaccination and the importance of routine immunization drives the demand for polio vaccines.
  • Government initiatives and collaborations between international organizations and vaccine manufacturers play a crucial role in ensuring widespread vaccine availability and accessibility.
  • Technological advancements in vaccine manufacturing and distribution contribute to the growth of the market.

Market Drivers:

  • Global initiatives to eradicate polio and achieve a polio-free world.
  • Increasing awareness about the importance of vaccination and the prevention of infectious diseases.
  • Government support and funding for immunization programs and routine vaccination campaigns.
  • Advancements in vaccine manufacturing technologies, including improved production methods and vaccine stability.
  • Collaboration between governments, international organizations, and vaccine manufacturers to ensure vaccine availability and accessibility.

Market Restraints:

  • Vaccine supply chain issues, including cold chain requirements and logistics challenges.
  • Vaccine hesitancy and misinformation, leading to lower vaccination rates and reduced demand for polio vaccines.
  • Safety concerns associated with vaccines, leading to vaccine refusal or reluctance among certain populations.
  • High costs associated with vaccine development, production, and distribution.
  • Vaccine-associated adverse events and rare cases of vaccine-derived polio.

Market Opportunities:

  • Expansion of immunization programs in low- and middle-income countries with high polio burden.
  • Introduction of new polio vaccine formulations with improved efficacy and safety profiles.
  • Technological advancements in vaccine manufacturing, such as the use of cell-based or recombinant vaccine production platforms.
  • Collaboration between governments, international organizations, and vaccine manufacturers to strengthen immunization infrastructure and increase vaccine coverage.
  • Development of combination vaccines that provide protection against multiple diseases, including polio.

Market Dynamics: The global polio vaccine market is driven by the efforts to eradicate polio and the implementation of immunization programs worldwide. Governments, international organizations, and vaccine manufacturers collaborate to ensure widespread vaccine availability, accessibility, and affordability. Technological advancements in vaccine manufacturing, including the use of cell-based or recombinant platforms, contribute to improved vaccine production efficiency and quality. However, challenges such as vaccine supply chain issues, vaccine hesitancy, and safety concerns pose barriers to market growth. Ongoing research and development activities focus on the development of new vaccine formulations and strategies to address these challenges and achieve global polio eradication.

Regional Analysis: The global polio vaccine market can be segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe have witnessed successful polio eradication campaigns and have low incidence rates of polio. In contrast, regions such as Asia Pacific, Latin America, and parts of Africa still experience polio transmission and have higher demand for polio vaccines. International organizations, governments, and vaccine manufacturers collaborate to support immunization programs and ensure vaccine availability in these regions.

Competitive Landscape: The global polio vaccine market is characterized by the presence of established vaccine manufacturers and collaborations between governments, international organizations, and vaccine manufacturers. Key players in the market include Sanofi Pasteur, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., and Bharat Biotech. These companies focus on research and development activities to develop and produce polio vaccines, ensuring quality, safety, and efficacy. Collaborations between manufacturers and organizations such as the World Health Organization (WHO) and Gavi, the Vaccine Alliance, play a vital role in supporting vaccine distribution and immunization programs.

Segmentation: The polio vaccine market can be segmented based on vaccine type, distribution channel, and end-user. Vaccine type segmentation includes inactivated polio vaccine (IPV) and oral polio vaccine (OPV). Distribution channel segmentation covers government immunization programs, private healthcare providers, and non-governmental organizations (NGOs). End-user segmentation includes pediatric and adult populations.

Category-wise Insights:

  • Inactivated polio vaccine (IPV) provides immunity against all three types of poliovirus and is typically administered through injection. It is commonly used in routine immunization programs and is recommended for individuals who cannot receive the oral polio vaccine (OPV).
  • Oral polio vaccine (OPV) is an attenuated live vaccine administered orally. It is easy to administer and has played a crucial role in polio eradication efforts. OPV provides immunity against all three types of poliovirus and induces intestinal immunity.
  • Government immunization programs play a vital role in providing polio vaccines to the population. These programs focus on routine immunization schedules, national immunization campaigns, and outreach programs targeting underserved populations.
  • Private healthcare providers also contribute to the distribution of polio vaccines, particularly for individuals seeking vaccination outside of government programs or during travel to polio-endemic areas.
  • Non-governmental organizations (NGOs) play a significant role in supporting immunization programs, vaccine delivery, and awareness campaigns, particularly in resource-constrained settings.

Key Benefits for Industry Participants and Stakeholders:

  • Contribution to global polio eradication efforts and the achievement of a polio-free world.
  • Revenue generation through vaccine production, distribution, and supply.
  • Collaboration opportunities with governments, international organizations, and healthcare providers.
  • Development of new vaccine formulations and technologies.
  • Impact on public health and prevention of polio-related disabilities and deaths.

SWOT Analysis: Strengths:

  • Global efforts to eradicate polio, driving demand for polio vaccines.
  • Established vaccine manufacturing capabilities and supply networks.
  • Strong immunization infrastructure and routine vaccination programs in many countries.
  • Collaboration between governments, international organizations, and vaccine manufacturers to support polioeradication goals.

Weaknesses:

  • Vaccine supply chain challenges, including cold chain requirements and logistics.
  • Vaccine hesitancy and misinformation impacting vaccine uptake.
  • Safety concerns and rare cases of vaccine-associated adverse events.

Opportunities:

  • Expansion of immunization programs in high-burden countries.
  • Introduction of new and improved polio vaccine formulations.
  • Technological advancements in vaccine manufacturing.

Threats:

  • Vaccine supply disruptions and distribution challenges.
  • Vaccine hesitancy leading to suboptimal vaccine coverage.
  • Emergence of vaccine-resistant poliovirus strains.

Market Key Trends:

  • Introduction of novel polio vaccine formulations, such as fractional dose IPV, to optimize vaccine supply and improve immunization coverage.
  • Increasing focus on routine immunization programs and catch-up campaigns to reach underserved populations.
  • Integration of polio vaccines with other childhood vaccines to improve vaccination efficiency.
  • Collaboration between governments, international organizations, and vaccine manufacturers to address supply chain issues and improve vaccine access.
  • Research and development activities to develop next-generation polio vaccines, including new vaccine candidates and combination vaccines.

Covid-19 Impact: The Covid-19 pandemic has had both positive and negative impacts on the polio vaccine market. On one hand, the pandemic has disrupted routine immunization programs and led to a decline in vaccine coverage. On the other hand, it has underscored the importance of vaccination and the need for robust immunization systems. Efforts are being made to ensure the continuity of polio immunization campaigns while adhering to Covid-19 safety protocols. The pandemic has also highlighted the importance of strong healthcare infrastructure and supply chains to ensure vaccine distribution.

Key Industry Developments:

  • Introduction of novel polio vaccine formulations, such as the switch from trivalent to bivalent OPV, as part of the polio endgame strategy.
  • Implementation of innovative vaccination strategies, including the use of mobile vaccination teams and community engagement programs.
  • Strengthening of surveillance systems to detect and respond to poliovirus outbreaks promptly.
  • Collaboration between governments, international organizations, and vaccine manufacturers to address vaccine supply chain challenges and improve vaccine distribution.

Analyst Suggestions:

  • Continued investment in research and development to develop new and improved polio vaccine formulations.
  • Collaboration with governments and international organizations to strengthen immunization systems and overcome vaccine supply chain challenges.
  • Addressing vaccine hesitancy through effective communication and education campaigns.
  • Enhancing surveillance and response systems to detect and respond to poliovirus outbreaks promptly.
  • Collaboration with other vaccine manufacturers and organizations to optimize vaccine production and ensure global availability.

Future Outlook: The global polio vaccine market is expected to witness steady growth in the coming years, driven by continued efforts to achieve polio eradication goals. Technological advancements in vaccine manufacturing, improved vaccine supply chains, and collaborations between stakeholders are expected to address existing challenges. The introduction of new vaccine formulations and strategies, coupled with robust immunization programs, will contribute to the eventual eradication of polio. However, ongoing surveillance and response efforts will remain critical to detect and respond to poliovirus outbreaks and prevent resurgence.

Conclusion: The global polio vaccine market plays a crucial role in preventing the transmission of the poliovirus and protecting individuals from polio infection. The market is driven by increasing awareness about the importance of vaccination, government initiatives to achieve polio eradication goals, and advancements in vaccine manufacturing technologies. Despite challenges such as vaccine supply chain issues and vaccine hesitancy, the market continues to grow, supported by collaborations between governments, international organizations, and vaccine manufacturers. Efforts to expand immunization programs, introduce new vaccine formulations, and strengthen surveillance and response systems are expected to contribute to the eventual eradication of polio.

Global Polio Vaccine Market:

Segmentation Details
Type Oral Polio Vaccine (OPV), Inactivated Polio Vaccine (IPV)
Age Group Infants, Children, Adults, Elderly
Distribution Channel Hospitals, Clinics, Pharmacies, Others
Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Leading Companies in Global Polio Vaccine Market:

  1. Sanofi Pasteur
  2. Serum Institute of India Pvt. Ltd.
  3. GlaxoSmithKline plc
  4. China National Pharmaceutical Group Corporation (Sinopharm)
  5. Walvax Biotechnology Co., Ltd.
  6. Panacea Biotec Ltd.
  7. PT Bio Farma (Persero) Tbk
  8. AstraZeneca plc
  9. Bharat Biotech
  10. Beijing Minhai Biotechnology Co., Ltd.

North America
o US
o Canada
o Mexico

Europe
o Germany
o Italy
o France
o UK
o Spain
o Denmark
o Sweden
o Austria
o Belgium
o Finland
o Turkey
o Poland
o Russia
o Greece
o Switzerland
o Netherlands
o Norway
o Portugal
o Rest of Europe

Asia Pacific
o China
o Japan
o India
o South Korea
o Indonesia
o Malaysia
o Kazakhstan
o Taiwan
o Vietnam
o Thailand
o Philippines
o Singapore
o Australia
o New Zealand
o Rest of Asia Pacific

South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America

The Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Israel
o Kuwait
o Oman
o North Africa
o West Africa
o Rest of MEA

Important Questions Covered in this Study

Why Choose MWR ?

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations.

Unlimited User Access

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions.

Free Company Inclusion

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges.

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met.

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis.

Client Associated with us

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

Client Testimonials

GET A FREE SAMPLE REPORT

This free sample study provides a complete overview of the report, including executive summary, market segments, competitive analysis, country level analysis and more.

error: Content is protected !!
Scroll to Top

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF
This website is safe and your personal information will be secured. Privacy Policy
Request for Discount
This website is safe and your personal information will be secured. Privacy Policy
Speak to Analyst
This website is safe and your personal information will be secured. Privacy Policy

Download Free Sample PDF